PETS Q3 2025 Earnings Call Summary | Stock Taper
Logo
PETS

PETS — PetMed Express, Inc.

NASDAQ


Q3 2025 Earnings Call Summary

February 10, 2025

PetMed Express Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

  • Net Sales: $53 million, down 19% from $65.3 million year-over-year.
  • Gross Profit: $14.9 million (28.1% of sales), compared to $17.9 million (27.3% of sales) last year.
  • Adjusted EBITDA: $2 million, up from $900,000 year-over-year.
  • Net Loss: $700,000 or $0.03 per diluted share, an improvement from a net loss of $2 million or $0.10 per diluted share last year.
  • General and Administrative Expenses: $10.8 million, down 19.7% from $13.4 million.
  • Advertising Expenses: $3 million, significantly reduced from $5.8 million last year.
  • Cash Position: $50 million in cash and equivalents, no debt.

2. Strategic Updates and Business Highlights

  • The company is focused on transforming PetMed and PetCareRx to become a leader in consumer pet healthcare.
  • Cost-cutting measures are in place, targeting $5 million in annualized savings through consolidation and operational efficiencies.
  • Enhanced digital shopping experience with a full website refresh and mobile app relaunch.
  • Introduced new payment options (Buy Now, Pay Later) and launched an educational platform (pethealthmd.com).
  • Achieved 84,000 gross new customers, with 63,000 having orders shipped in the quarter.
  • Improved inventory efficiency with a 66% reduction in total inventory on hand and an increase in inventory turnover to 1.5.

3. Forward Guidance and Outlook

  • The company anticipates continued investments in customer engagement and acquisition strategies.
  • Plans to refine marketing strategies to ensure sustainable growth, with a focus on improving customer experience and operational efficiency.
  • Acknowledges the need for a strategic reset in marketing, with expectations to ramp up spending as foundational improvements are made.

4. Bad News, Challenges, or Points of Concern

  • Experienced three consecutive quarters of double-digit revenue declines, attributed to a highly competitive environment and reduced advertising spend.
  • Customer acquisition and sales fell short of expectations due to prioritizing margin protection over aggressive promotions.
  • The market is seeing pressure on consumer spending, particularly among lower-income households, which may impact sales.
  • The need to capture younger demographics (millennials and Gen Z) remains a challenge, as the company transitions its marketing approach.

5. Notable Q&A Insights

  • Clarified that the 63,000 new customers reported had shipped orders, emphasizing the importance of customer retention.
  • SKU rationalization did not significantly impact revenue, as most eliminated SKUs were underperforming and drop-shipped.
  • The management acknowledged ongoing pressure on customers and noted a shift in spending patterns, with higher-income households continuing to spend on pet healthcare.
  • Plans for increased marketing investment are contingent on foundational improvements in customer experience and operational capabilities, with an emphasis on timely product delivery.

Overall, while PetMed Express is making strides in its strategic transformation and cost management, it faces significant challenges in revenue growth and market competition. The company is focused on enhancing customer experience and refining its marketing strategies to drive future growth.